Collapse all Expand all Background Interleukin‐1 (IL‐1) blocking agents have been used for treating severe coronavirus disease 2019 (COVID‐19), on the premise that their immunomodulatory effect might be beneficial in people with COVID‐19. Objectives To assess the effects of IL‐1 blocking agents compared with standard care alone or with placebo on effectiveness and safety outcomes…
The Cochrane Library is a collection of high-quality, independent evidence to inform healthcare decision-making, including the Cochrane Database of Systematic Reviews and the CENTRAL register…
Alongside its many reviews of possible treatments for dementia, the Cochrane Dementia and Cognitive Improvement Group produced reviews relevant to other aspects of the care…
Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how…
Among the Cochrane Reviews of treatments to help patients with kidney stones, our review comparing shock wave treatment with surgery was updated for the second…
There are three different sorts of PICOs within Cochrane Reviews. PICO stands for four different potential components of a health question used in Cochrane Review…
Among the Cochrane Reviews of treatments to help patients with kidney stones, our review comparing shock wave treatment with surgery was updated for the second…
Two of the Cochrane Reviews that investigate different ways to deliver health and social care services look at the qualitative and quantitative research into a…
Immunisation is a key component in the prevention of illness and the Cochrane review of interventions to improve coverage of childhood immunisation in low- and…
Door-to-door tuberculosis (TB) screening and contact tracing can improve diagnosis rates, but must be paired with effective follow-up care to be successful, a new Cochrane…
